CDKN1C hyperexpression in two patients with severe growth failure and microdeletions affecting the paternally inherited KCNQ1OT1:TSS-DMR

J Med Genet. 2022 Dec;59(12):1241-1246. doi: 10.1136/jmg-2022-108700. Epub 2022 Jul 29.

Abstract

Background: Two imprinting control centres, H19/IGF2:IG-differentialy methylated region (DMR) and KCNQ1OT1:TSS-DMR, reside on chromosome 11p15.5. Paternal deletions involving the KCNQ1OT1:TSS-DMR result in variable phenotypes, namely, normal phenotype, Silver-Russel syndrome (SRS) and fetal demise. However, expression analyses for CDKN1C in these patients are very limited.

Cases: Patient 1 (adult woman) and patient 2 (boy in early childhood) showed prenatal and postnatal growth failure and clinical suspicion of SRS.

Molecular analyses: Both patients showed hypermethylation of the KCNQ1OT1:TSS-DMR caused by the paternal heterozygous de novo deletions involving the KCNQ1OT1:TSS-DMR, but not including CDKN1C enhancers. The deletion sizes were 5 kb and 12 kb for patients 1 and 2, respectively. CDKN1C gene expressions in immortalised leucocytes of both patients were increased compared with those of controls.

Conclusion: Paternal deletions involving the KCNQ1OT1:TSS-DMR, but not including CDKN1C enhancers, disrupt KCNQ1OT1 expression, strongly activate CDKN1C expression and consequently cause severe growth failure.

Keywords: epigenomics; human genetics.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Cyclin-Dependent Kinase Inhibitor p57 / genetics
  • DNA Methylation / genetics
  • Failure to Thrive / genetics
  • Female
  • Genomic Imprinting / genetics
  • Humans
  • Paternal Inheritance
  • Phenotype
  • Pregnancy
  • RNA, Long Noncoding* / genetics
  • Silver-Russell Syndrome* / genetics

Substances

  • RNA, Long Noncoding
  • CDKN1C protein, human
  • Cyclin-Dependent Kinase Inhibitor p57